Anuh Pharma Limited has submitted a clarification letter to the Manager (Listing) of BSE Limited and the Listing Compliance Department of the National Stock Exchange of India Limited.

The purpose of the disclosure is to correct errors that appeared in a newspaper publication. The publication, related to the transfer of equity shares to the Investor Education and Protection Fund (IEPF), was published in the Mumbai Lakshdeep (Marathi Edition) newspaper on 19th June, 2026.

The clarification specifies two incorrect website URLs that were published:

  • The company website was incorrectly listed as www.anuhapharma.com and should be corrected to www.anuhpharma.com.
  • The IEPF authority website was incorrectly listed as www.efo.gov.in and should be corrected to www.iepf.gov.in.

The company has confirmed that this clarification letter has also been made available on its correct website, www.anuhpharma.com.

The letter was signed by Manan Vadhan, Company Secretary & Compliance Officer, from Mumbai on 20th June, 2026 at 18:49:36 IST.